The Japan Agency for Medical Research and Development (AMED) will double down on efforts to boost coordination between different funding projects under its new president Hitoshi Nakagama by modifying how it supports healthcare R&D in the country. Nakagama, who took…
To read the full story
Related Article
- NCC President Nakagama to Lead AMED from April
March 26, 2025
- AMED President Mishima Hints at Resignation
March 25, 2025
REGULATORY
- Pharma Urges Pricing Rewards to Bolster Japan’s Drug Discovery Strength
September 24, 2026
- New Digital Minister Furukawa Pledges Push for Healthy Longevity
September 24, 2026
- MHLW Eyes Higher Long-Term Care Premiums for Wealthier Seniors
September 24, 2026
- Nippon Ishin’s Urano Named Senior Vice Health Minister in Takaichi Cabinet
September 24, 2026
- Ueno Vows to Advance Drug Innovation, Advanced Medicine in 2nd Term
September 24, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





